For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at ...
Mirum Pharmaceuticals, Inc. today reported financial results for the third quarter 2025 and provided a business update. "Mirum is well positioned heading into 2026 with strong commercial momentum and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback